22 June 2026
22 June 2026
RLTs were a hot topic at ASCO 2026, but experts note that certain limitations must be addressed to facilitate their widespread use in cancer care.
The panel unanimously said that the benefits of Moderna's mRNA jab outweigh its risks in preventing influenza in certain age groups.
Experts note that adherence-focused health technologies should be flexible, engaging, adaptable and affordable to the patient or healthcare system.
Sun Pharma expects to close the acquisition on or before 31 July 2026.
The approved indications include combining Sarclisa SC with Pd, or with carfilzomib for relapsed or refractory multiple myeloma.
GlobalData says that the industry has “absorbed significant disruption”, with high M&A levels testament to recovery.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
